Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FLT3 mutation + DNMT3A mutation
i
Other names:
DNMT3A, DNA Methyltransferase 3 Alpha, DNA (Cytosine-5-)-Methyltransferase 3 Alpha, DNA (Cytosine-5)-Methyltransferase 3A, DNA MTase HsaIIIA, DNA Cytosine Methyltransferase 3A2, DNA Methyltransferase HsaIIIA, DNMT3A2, Dnmt3a, FLT3, Fms Related Tyrosine Kinase 3, Receptor-Type Tyrosine-Protein Kinase FLT3, Stem Cell Tyrosine Kinase 1, Fms-Like Tyrosine Kinase 3, CD135, FLK-2, STK1, Growth Factor Receptor Tyrosine Kinase Type III, Fetal Liver Kinase 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2322
;
1788
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
TET2 deletion + DNMT3A mutation (4)
NUP98-NSD1 fusion + FLT3-ITD mutation (3)
CD123 positive + FLT3-ITD mutation (1)
CSK overexpression + FLT3-ITD mutation (1)
EPHB2 overexpression + FLT3-ITD mutation (1)
FLT3 A848P + MLL-MLLT3 fusion (1)
FLT3 wild-type + TP53 mutation (1)
FLT3-ITD mutation + MLL fusion + TP53 mutation (1)
FLT3-ITD mutation + PML-RARA fusion + WT1 overexpression (1)
FLT3-ITD mutation + RIPK1 expression (1)
FLT3-ITD mutation + SKI overexpression (1)
HCK overexpression + FLT3-ITD mutation (1)
HLF overexpression + FLT3-ITD mutation (1)
KAT6A-CREBBP fusion + FLT3-TKD mutation (1)
LYN overexpression + FLT3-ITD mutation (1)
miR-155 deletion + FLT3-ITD mutation (1)
ALK positive + DNMT3A N403Tfs* (1)
TET2 deletion + DNMT3A mutation (4)
NUP98-NSD1 fusion + FLT3-ITD mutation (3)
CD123 positive + FLT3-ITD mutation (1)
CSK overexpression + FLT3-ITD mutation (1)
EPHB2 overexpression + FLT3-ITD mutation (1)
FLT3 A848P + MLL-MLLT3 fusion (1)
FLT3 wild-type + TP53 mutation (1)
FLT3-ITD mutation + MLL fusion + TP53 mutation (1)
FLT3-ITD mutation + PML-RARA fusion + WT1 overexpression (1)
FLT3-ITD mutation + RIPK1 expression (1)
FLT3-ITD mutation + SKI overexpression (1)
HCK overexpression + FLT3-ITD mutation (1)
HLF overexpression + FLT3-ITD mutation (1)
KAT6A-CREBBP fusion + FLT3-TKD mutation (1)
LYN overexpression + FLT3-ITD mutation (1)
miR-155 deletion + FLT3-ITD mutation (1)
ALK positive + DNMT3A N403Tfs* (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
venetoclax
Sensitive: C3 – Early Trials
venetoclax
Sensitive
:
C3
venetoclax
Sensitive: C3 – Early Trials
venetoclax
Sensitive
:
C3
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
ixazomib
Resistant: D – Preclinical
ixazomib
Resistant
:
D
ixazomib
Resistant: D – Preclinical
ixazomib
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.